DAIC

MARCH 7, 2024

The CardiAMP HF trial is supported by the Maryland Stem Cell Research Fund and has reimbursement from the Centers for Medicare and Medicaid Services (CMS) for both treatment and control procedures. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

DAIC

FEBRUARY 1, 2024

Elevated levels of two protein biomarkers that indicate heart damage were associated with undetected or symptomless cardiovascular disease in adults with Type 2 diabetes compared to those without Type 2 diabetes, according to new research published May 31, 2023, in the Journal of the American Heart Association, JAHA.

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Peripheral Arterial Disease Strokes 104

CardiacWire

DECEMBER 3, 2023

Jimenez: Accucardia is an ECG-led diagnostics company, leveraging ECG as a broad biomarker for cardiology and beyond. Some cardiac monitoring companies have also outsourced these interpretations to cardiac technicians outside of the US in order to manage their increasing volumes and offset margin pressures from reimbursement rate reductions.

Arrhythmia 52

Arrhythmia Atrial Flutter Reimbursement Atrial Fibrillation 52